Loading...
XNAS
ACLS
Market cap4.39bUSD
Jul 09, Last price  
142.93USD
1D
5.54%
1Q
29.50%
Jan 2017
882.34%
IPO
38.07%
Name

Axcelis Technologies Inc

Chart & Performance

D1W1MN
XNAS:ACLS chart
P/E
36.53
P/S
5.24
EPS
3.91
Div Yield, %
Shrs. gr., 5y
-1.49%
Rev. gr., 5y
12.07%
Revenues
839m
-17.57%
461,717,000404,800,000250,214,000133,022,000275,212,000319,416,000203,385,000195,632,000203,051,000301,495,000266,980,000410,561,000442,575,000342,958,000474,560,000662,428,000919,998,0001,130,604,0001,017,865,000839,048,000
Net income
120m
-40.18%
40,770,000-11,398,000-196,664,000-77,468,000-17,573,0005,077,000-34,034,000-17,144,000-11,266,00014,678,00011,001,000126,959,00045,885,00017,034,00049,982,00098,650,000183,079,000246,263,000200,992,000120,238,000
CFO
118m
-15.99%
19,018,000-31,104,000-48,719,000-33,942,000-5,892,0003,533,000-10,597,000-15,042,000-16,048,00018,259,000-8,799,00056,284,00046,965,000-13,594,00069,703,000150,190,000215,607,000156,869,000140,818,000118,305,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semiconductor chips. Operating internationally, its presence extends across North America, Europe, and Asia. The firm offers a wide array of implanter technologies, such as high-energy, high-current, and medium-current systems, designed to meet diverse application needs. Furthermore, Axcelis provides extensive post-sales support and lifecycle solutions, including the sale of pre-owned equipment, replacement parts, system upgrades, ongoing maintenance, and client instruction. It directly furnishes its advanced equipment and services to microchip manufacturers through its own dedicated sales personnel. Founded in 1978, Axcelis Technologies has its corporate headquarters situated in Beverly, Massachusetts.
IPO date
Jul 11, 2000
Employees
1,388
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT